請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32850
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江俊斌 | |
dc.contributor.author | Hung-Ming Tsai | en |
dc.contributor.author | 蔡鴻明 | zh_TW |
dc.date.accessioned | 2021-06-13T04:17:09Z | - |
dc.date.available | 2006-08-04 | |
dc.date.copyright | 2006-08-04 | |
dc.date.issued | 2006 | |
dc.date.submitted | 2006-07-25 | |
dc.identifier.citation | Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948; 23: 670-8.
Adams, JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992; 40: 1457-63. Aggelopoulou EFI, Skarlos D, Papadimitriou C, Kittas C, Troungos C. Human papilloma virus DNA detection in oral lesons in the Greek population. Anticancer Res 1999; 19: 1391-6. Adler-Storthz K, Newland JR, Tessin BA, Yendall WA, Shillitoe EJ. Human papillomavirus type 2 DNA in oral verrucous carcinoma. J Oral Pathol 1986; 15: 472-5. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, Klein W, Helbig M, Dietz A, Weidauer H, Bosch FX. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinoma lacking retinoblastoma cell cycle control. Cancer Res 1998; 588: 5-13. Ashcroft M, Taya Y, Vousden KH. Stress singals use mutiple pathways to stabilize p53. Mol Cell Biol 2000; 20: 3224-33. Atula S, Grenman R, Laippala P, Syrjanen S. Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg 1996; 122: 1313-9. Badaracco G, Venuti A, Morello R, Muller A, Marcante ML. Human papillomavirus in head and neck carcinomas: Prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 2000; 20: 1301-6. Baker KH, Feldman JE. Cancers of the head and neck. Cancer Nurs 1987; 10: 293–9. Balaram P, Nalinakumari KR, Abraham E, Balan A, Hareendran NK, Bernard HU, Chan SY. Human papillomaviruses in 91 oral cancers from Indian betel quid chewers – High prevalence and multiplicity of infections. Int J Cancer 1995; 61: 450-4. Bartek J, Barkova J, Vojtesek B, Stakova Z, Rejthar A, Kovarik J, Lane DP. Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer 1990; 46: 839-44. Bauer HM, Greer CE, Manos MM. Determination of genital human papillomavirus infection by consensus PCR amplification. In: Herrington CS, McGee JO, editors. Diagnostic molecular pathology: a practical appoach. Vol II. Cell and tissue genotyping. Oxford: IRL Press at Oxford University Press. 1992; p131-152. Bergeron C, Ferenczy A, Richart R Underwear: contamination by human papillomavirus infection. Epidermiol Rev 1990; 10: 122-63. Blons H, Laurent-Puig P. TP53 and head and neck neoplasms. Hum Mutat 2003; 21: 252–7. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Berstein L, Schoenberg JB, Stemhagen A, Fraumeni JF Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ. Catalyzed reporter deposition, a noval method of signal amplifiaction. Application to immunoassays. J Immunol Methods 1989; 125: 279-85. Bobrow MN, Litt GJ, Shaghnessy KJ, Mayer PC, Conlon J. The use of catalyzed reporter depostion as a means of signal amplification in a variety of formats. J Immunol Methods 1992; 150: 145-9. Bouda M, Gorgoulis VG, Kastrinakis NG, Giannoundis A, Tsoli E, Afentaki DD, Foukas P, Kyroudi A, Laskaris G, Herrington CS, Kittas C. “High types” are frequently detected in potentially malignant and malginant oral lesions, but not in normal oral mucosa. Mod Pathol 2000; 13: 644-53. Byers RM. Squamous cell carcinoma of the oral tongue in patients less than thirty years of age. Am J Surg 1975; 130: 475-8. Cann CI, Fried MP, Rothman KJ. Epideminology of squamous cell carcinoma of the head and neck. Otolaryngol Clin North Am 1985; 18: 367-88. Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2) /M checkpoint. Genes Dev 2000; 14: 1584-8. Chang F, Syrjanen SM, Kellokoski J, Syrjanen KJ. Human papillomavirus (HPV) infection and their associations with oral disease. J Oral Pathol Med 1991; 20: 305-17. Chang JYF, Lin MC, Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol 2003; 120; 909-16. Chang KC. Su IJ. Tsai ST. Shieh DB. Jin YT. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association. Oncology 2002; 63: 362-9 Chang KW, Chang CS, Lai KS, Chou MJ, Choo KB. High prevalence of human papillomavirus infection and possible association with betel quid chewing and smoking in oral epidermoid carcinomas in Taiwan. J Med Virol 1989; 28: 57–61. Chen PCH, Kuo C, Pan CC, Chou MY. Risk of oral cancer assoicated with human papillomavirus infection, betel quid chewing and cigarette smoking in Taiwan – an integrated molecular and epidemiologyical study of 58 cases. J Oral Pathol Med 2002; 31: 317-22. Chen YK, Huang HC, Lin LM, Tsai CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol 1999; 35: 173-9. Clarke RW, Stell PM. Squamous cell carcinoma of the head and neck in the young adult. Clin Otolaryngol 1992; 17: 18-23. Cruz IBF, Snijders PJ, Steenbergen RD, Meijer CJ, Snow GB, Wallboomers JM, van der Waal I. Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J of Cancer B Oral Oncol 1996; 32B: 55-62. Cusumano RJ, Persky MS. Squamous cell carcinoma of the oral cavity and oropharynx in young adults. Head Neck Surg 1988; 10: 229-34. De Villers EM, Wendauer H, Otto H, zur Hausen H. Papillomavirus DNA in human tongue carcinomas. Int J Cancer 1985; 36: 575-8. Decker J, Goldstein JC. Current concepts in otolaryngology. Risk factors in head and neck cancer. N Engl J Med 1982; 306: 1151-6. Department of Health, The Executive Yuan, Taiwan. Cancer registry annual report, RCO (2005). Dirks RW. RNA molecules lightingup under the microscope. Histochem Cell Biol 1996; 106: 151-66. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci USA 2000; 97: 10002-7. Durst M, Dzarlieva-Petrusevaska RT, Boukamp P, Fusening NE, Gissmann L. Molecular and cytogenetic analysis of immortalized primary human keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1987; 1: 251-6. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-7. Eisenberg E, Rosenberg B, Krutchkoff DJ. Verrucous carcinoma: a possible viral pathogenesis. Oral Surg Oral Med Oral Pathol 1985;59: 52-7. Elamin F, Steingrimsdottir H, Wanakulasuriya S, Johnson N, Tavassoli M. Prevalence of human papillomavirus infection in premalignant and malignant lesions of the oral cavity in U.K. subjects: a novel method of detection. Oral Oncol 1998; 34: 191-7. Evans MF, Mount SL, Beatty BG, Cooper K. Biotinyl-tyramide-based in situ hybridization singal patterns distinguish human papillomavirus type and grade of cervial intraepithelial neoplasia. Mod Pathol 2002; 15: 1339-47. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu p, Simard P, Russo PA, Yotor WV. A two –tier polymerase chain reaction direct sequencing method for detecting and typing human papillomaviruses in pathological specimens. Diadn Mol Pathol 1998b; 7: 317-23. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu p, Simard P, Russo PA, Yotor WV. JC9813-A Putative Novel Human Papillomavirus Identified by PCR-DS. Biochem Biophys Res Commun 1998; 250: 63-7. Ferenzy A, Bergeron C, Richart RM. Human papillomavirus DNA in formites onobjects used for the management of patients with genital human papillomavirus infections. Obstet Gynaecol 1989; 74: 950-4. Fliss DM. Noble-Topham SE. McLachlin M. Freeman JL. Noyek AM. van Nostrand AW. Hartwick RW. Laryngeal verrucous carcinoma: a clinicopathologic study and detection of human papillomavirus using polymerase chain reaction. Laryngoscope 1994; 104: 146-52 Forozan F, Karhu R, Kononen J, Kallioniemi A, kallioniemi O-P. Genome screening by comparative genomic hybridization. Trends Genet 1997; 13: 405-9. Galloway DA, McDougall JK. The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin Cancer Biol 1996; 7: 309-15. Gillision ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Sidransky D. Evidence for a casual association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-20. Gorgoulis VG, Zaharatos P, Kotsinas A, Hyroudi A, Tassidakis AN, Ikonompoulos JA. Human papilloma virus (HPV) is possibly involved in laryngeal but not in lung carcinogenesis. Hum Pathol 1998; 30: 274-83. Graeber AJ. Osmanian C, Jack T, Housman DE, Koch CJ, Lowe SW, Graccia AJ. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 1996; 379: 88-91. Graham S. Dentition, diet tobacco and alchol in the epidemiology of oral cancer. J Natl Cancer Inst 1977; 59: 1611-8. Greer RO, Eversole LR, Crosby LK. Detection of human papillomavirus-genomic DNA in oral epithelial dysplasia, oral smokeless tobacco-associated leukoplakia, and epithelial malignancies. J Oral Maxillofac Surg 1990; 48: 1201-5. Hill A. The environment and disease: association or causation. Proc R Soc Med 1965; 58: 295-300. Hindle I, Downer MC, Speight PM. The epideminology of oral cancer. Br J Oral Maxillofac Surg 1996; 34: 471-6. Hofler H. In situ polymerase chain reaction: toy or tool? Histochem 1993; 99: 103-4. Holfer H, Childers H, Montminy MR, Lechan RM, Goodmann RH, Wolfe HJ. In situ hybridization methods for the detection of somatostatin mRNA in tissue sections using antisense RNA probes. Histochem J 1986; 18: 597-604. Hopman AHN, Voorter CRM, Speel EJM, Ramaekers FCS. In situ hybridization and comparative hybridization. In Wolman SR, Sell S. eds. Cytogenetic Cancer Markers. Totowa, NJ, Humana Press, pp. 45-69. Huang HJ, Huang SL, Lin Cy, Lin RW, Chao FY, Chang TC, Hsueh S, Hsu KH, Lai CH. Human papillomavirus genotyping by a PCR based genechip method in cervical carcinoma treated with neoadjuvant chemotherapy plus radical surgery. Int J Gynecol Cancer 2004; 14: 639-49. International Union Against Cancer. TNM classification of malignant tumors. Sobin LH, Wittekind C, eds. 5th ed. New York: Weley-Liss, 1997; 17-43. Jacobs MV, Snijder PJ, van der Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6+ mediated PCR-enzyme immunoassay method for repaid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-5. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26. Jeon S, Allen-Hoffmann BL, Lambert PF. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 1995; 69: 2989-97. Jeon S, Lambert PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increase stability of E6 and E7 mRNAs; Implication for cervical carcinogenesis. PNAS 1995; 92: 1654-8. Johnson TL, Plieth DA, Crissman JD, Sarkar FH. HPV detection by polymerase chain reaction (PCR) in verrucous lesions of the upper aerodigestive tract. Mod Pathol 1991; 4: 461. Jones JB, Lampe HB, Cheung HW. Carcinoma of the tongue in young adults. J Otolaryngol 1989; 18: 105-8. Karlsen F, Kristensen G, Holm R, Chitemerere M, Berner A, Hagmar BM. High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions. Eur J Cancer 1995; 31A: 1511–6. Kaye JN, Starkey WG, Kell B, et al. Human papillomavirus type-16 in infants: use of DNA sequence analyses to establish the source of infection. J Gen Virol 1996; 77: 1139-43. Kleist B, Bankau A, Lorenz G, Jager B, Poetsch M Different Risk Factors in Basaloid and Common Squamous Head and Neck Cancer Laryngoscope 2004; 114: 1063-8 Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM Tsai CC. Betel quid chwing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pthol Med 1995; 24: 450-3. Komminoth P, Long AA, In-situ polymerase chain reaction. An overview of methods, applications and limitations fo a new molecular technique. Virchows Arch 1993[B]; 64: 67-73. Krolls SO, Hoffman S. Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14253 cases by age, sex and race of patients. J Am Dent Assoc 1976; 92: 571-4. Kuriakose M, Sankaranarayanan M, Nair MK, Cherian T, Sugar AW, Scully C, Prime SS. Comparison of oral squamous cell carcinoma in young and older patients in India. Eur J Cancer B Oral Oncol 1992; 28B: 113-20. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formosan Med Assoc 1976; 75: 497-505. Lakshmi S, Nair SA, Pillai MR, Oral cancer and human papillomaviruses: is there a link? J Surg Oncol 1993; 52: 193-6. La Vecchia C, Franceschi S, Levi F, Lucchini F, Negri E. Diet and human oral carcinoma in Europe. Eur J Cancers B Oral Oncol 1993; 29B: 17-22. Lazo PA, Gallego MI, Ballester S, Feduchi E. Genetic alternations by human papillomaviruses in oncogenesis. FEBS Lett 1992; 300: 109-13. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol 2001: 13: 176-82. Liu X, Han S, Baluda MA, Park NH, HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral kerationcytes. Oncogene 1997; 14: 2347-53. Llewellyn CD, Johnson NW, Warankulasuriya, KAAS. Risk factors for squamous cell carcinoma of the oral cavity in young peple – a comprehensive literature review. Oral Oncol 2001; 37: 401-18. Lu CT, Yen YY, Ho CS, et al. A case-control study of oral cancer in Changhua County, Taiwan. J Oral Pathol Med 1996; 25: 245–8. Lubbe J. Kormann A. Adams V. Hassam S. Gratz KW. Panizzon RG. Burg G HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology 1996; 192: 217-21 Macfarlane GJ, Boyle P, Evstifeeva TV, Robertson C, Scully C. Rsising trends of oral cancer mortaliy among males worldwide: the return of an old public health problem. Cancer Causes Control 1994; 5: 259-65. Mashberg A. Erythroplasia. The earliest sign of asymptomatic oral cancer. J Am Dent Assoc 1978; 96: 615-20. Medina JE, Dichtel W, Luna MA. Verrucous squamous carcinoma of the oral cavity; a clinicopathologic study of 104 cases. Arch Otolaryngol 1984; 110: 437-40. Mee AP, Denton J, Hoyland JA, Davis M, Mawer EB. Quantification of vitamin D receptor m RNA in tissue sections demonstrates the relative limitations of in situ reverse transcriptase polymerase chain reaction. J Pathol 1997; 182: 22-28. Melchers W, van Den Brale A, Walboomers J. Increased detection rate of human papillomavirus in cervical scrapes by the polymerase chain reaction as compared to modified FISH and Southern blot analysis. J Med Virol 1989; 27: 329-35. Merz H, Malisius R, Mannweiler S, Zhou R, Hartmann W, Orscheschek K, Moubayed P, Feller AC. Immunomax. A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest 1995; 73: 149-56. Milde K, Loning T. Detection of papillomavirus DNA in oral papillomas and carcinoma: Application of in situ hybridization with biotinylated HPV 16 probes. J Oral Pathol 1986; 15: 292-6. Miller CS, White DK. Human papillomavirus expression in oral mucosa, premalignant conditions and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 82: 57-68. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: A meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 622-35. Mitsuishi T, Kuniaki O, Makoto K, Kobayashic S, Kawana S Prevalence of human papillomavirus DNA sequences in verrucous carcinoma of the lip: genomic and therapeutic approaches. Cancer Letters 2005; 222: 139-43 Munger K, Scheffner M, Huibregtse JM, Howley PM. Interactions of HPV E6 and E7 oncoproteins with tumor suppressor gene products. Cancer Surv 1992; 12: 197-217. Munger K, Werness BA, Dyson N, Phelps W, Harlow E, Howley P. Complex formation of human papillomavirus E7 protiens with the retinoblastoma tumor suppressor gene product. EMBO J 1989; 8: 4099-105. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 1222: 44-51. Noble-Topham SE, Fliss DM, Hartwick RWJ, Mclachlin CM, Freeman JL, Noyek AM, et al. Detection of human papillomavirus in verrucous carcinoma of the oral cavity using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993; 119: 1299-304. Oda D, Bigler L, Lee P, Blanton R. HPV immortalization of human oral epithelial cells: a model for carcinogenesis. Exp cell Res 1996; 226: 164-9. Oliver RJ. Oral cancer in young adults: reports of three cases and review of the literature. Br Dent J 2000; 188: 362-6. Park NH, Min BM, LiSL, Haung MZ, Cherrick HM, Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis (Lond.) 1991; 12: 1627-31. Pfister H, Fuchs PG, Volcker HE. Human papillomavirus DNA in conjunctival papilloma. Graefes Arch Clin Exp Ophthamol 1985; 223: 164-7. Pitman KT, Johnson JT, Wagner RL, Myers EN. Cancer of the tongue in patient less than forty. Head Neck 2000; 22: 297-302. Rajendran R, Varghese I, Sugathan CK, Vijayakumar T. Ackerman’s tumor (verrucous carcinoma) of the oral cavity: a clinicoepideminologicstudy of 426 cases. Aust Dent J 1988; 33: 295-8. Reichart P, Mohr U. Correlation between chewing and smoking habits and precancerous lesions in hill tribes of northern Thailand. IARC. Lyon: Scientific Publications, 1987; 463-4. Rennie JS, McGregor AD. Intraoral squamous cell carcinoma in patients under 40 years of age. A report of 13 cases and review of the literature. Br J Plastic Surg 1987; 40: 270-3. Rinstrom E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human Papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 3187-92. Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH. Human papillomavirus infection as a prognostic factor in carcinoma of the oral cavity and oropharynx. Int J Cancer 2003; 104: 336-44. Romanov SR, Kozakiewicz BW, Holst CR, Stampfer MR, Haupt LM, Tlsty TD. Normal human mammary epithelial cells spontaneously escape and acquire genomic changes. Nature 2001; 409: 633-7. Sanghvi LD. Cancer epidemiology: the Indian scene. J Cancer Res Clin Oncol 1981; 99: 1-14. Sanno N, Teramoto A, Sugiyama M, Itoh Y, Osamura RY. Applicaton of catalyzed signal amplification n immunodetection of gonadotropin subunits in clinically nonfunctioning pituitary adenomas. Am J Clin Pathol 1996; 106: 16-21. Sarkaria M, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 1994; 16: 107-11. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958-64. Sexton CJ, Proby CM, Banks L, Stables JN, Powell K, Navsaria H, Leigh IM. Characterization of factors involved in human papillomavirus type 16-mediated immortalization of oral keratinocytes. J Gen Virol 1993; 74: 755-61. Shamanin V, Glover M, Rausch C, et al. Specific types of human papillomavirus found in benign proliferations and carcinomas of the skin in immunosuppressed patients. Cancer Res 1994; 54: 4610-3. Shillitoe EJ. Relationship of viral infection to malignancies. Curr Opin Dent 1991; 1: 398-403. Shope RE, Hurst EW. Infectious papillomatosis of rabbits. J Exp Med 1933; 58: 607-23. Shroyer KR. Greer RO. Detection of human papillomavirus DNA by in situ hybridization and polymerase chain reaction in premalignant and malignant oral lesions. Oral Surg Oral Med Oral Pathol 1991; 71: 708-13. Shroyer KR. Greer RO. Fankhouser CA. McGuirt WF. Marshall R. Detection of human papillomavirus DNA in oral verrucous carcinoma by polymerase chain reaction. Modern Pathology. 1993; 6: 669-72 Sisk EA, Bradford CR, Jacob A, Yian CH, Staton KM, Tang G, Garey TE, Lancaster WD, Gregoire L. Huamn papillomavirus infection in “young” versus “old” patients with squamous cell carcinoma of the head and neck. Head Neck 2002; 22: 649-57. Slootweg PJ, Muller H. Verrucous hyperplasia or verrucous carcinoma: an analysis of 27 patients. J Maxillofac Surg 1983; 11: 13-9. Smith EM. Epideminology of oral and pharyngeal cancers in the United States: review of recent literature. JNCI 1979; 63: 1189-98. Snijders PJ, van den Brule AJ, Meijer CJ, Walboomers JM. Papillomaviruses and ancer of the upper digestive and respiratory tracts (Review). Curr Top Microbiol Immunol 1994; 186: 177-98. Son YH, kapp DS. Oral cavity and oropharyngeal cancer in a younger population. Cancer 1985; 55: 441-1. Sonnex C, Strauss S, Grey JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Inf 1999; 75: 317-9. Southern SA, Herringtion CS. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gyncol Cancer 2000; 10: 263-74. Speel EJM, Lawson D, Hopman AHN, Gosden J. Multii-PRINS: mutiple sequential oligonucleotide primed in situ DNA synthesis reactions label specific chromosomes and produce bands. Human Genet 1995; 95: 29-33. Speel EJM, Hopman AHN, Komminoth P. Amplification methods to increase the sensitivity of in situ hybridization: play CARD(s). J Histochem Cytochem 1999; 47: 281-8. Sugerman PB, Joseph BK, Savage NW. The role of oncogenes, tumor suppressor genes and growth factors in oral squamous cell carcinoma: a case of apotosis versus proliferation. Oral Dis 1995; 1: 172-88. Sugerman PB, Shillitoe EJ. The high risk human papillomavirus and oral cancer: evidence for and against a causal relationship. Oral Dis 1997; 3: 130-47. Sugiyama M, Bhawal UK, Dohmen T, Onom S, Miyauchi M, Ishikawa T. Detection of human papillomavirus–16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 594-600. Thomas S, Kearsley J. Betel quid and oral cancer: a review. Eur J Cancer B Oral Oncol 1993; 29B: 251-5. Thomas SJ, MacLennan R. Slaked lime and betel nut cancer in Papua New Guinea. Lancet 1992; 340: 577–8. Tindle RW, Frazer IH. Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunilzation. Curr Top Microbiol Immunol 1994; 186: 217-53. Uobe K, Masuno K, Fang YR, Li LJ, Wen YM, Ueda Y, Tanaka A. Detection of HPV in Japanese and Chinese oral carcinomas by in situ PCR. Oral Oncol 2001; 37: 146-52. Van GijlswijkRPM, Zijlmans HJMAA, Wiegant J, Bobrow MN, Erickson TJ, Adler KE, Tanke HJ, Raap AK. Fluorochrome-labeled tyramides: use in immnocytochemistry and fluorescence in situ hybridization. J Histochem Cytochem 1997; 45: 375-82. Van Ranst M, Kaplan JB, Burk RD. Phylogenetic calssification of human papillomaviruses. J Gen Virol 1992; 73: 2653-60. Von Wasielewski R, Mengel M, Gignac S, Wilkens L, Werner M, Georgii A, Tyramine amplification technique in routine immunohistochemistry. J Histochem Cytochem 1997; 45: 375-82. Walbomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9. Walboomers JM, Husman AM, van cer Brule AVC, Snijders PJ, Meier CJ. Detection of genital human papillomavirus infections: critical review of methods and prevalence stuies in relationship to cervical cancer. In: Stern PL, Stanley MA eds: Human papillomaviruses and cervical cancer : biology and immunology. New York: Oxford University Press, 1994; 40-71. Watts SL, Brewer EE, Fry TL. Human Papillomavirus DNA ypes in squamous cell carcinoma of the head and neck. Oral Surg Oral Med Oral Pathol 1991; 71: 701-7. Wilczynski SP, Lin BT, Xie Y, Paz IB. Detection of human papillomavirus DNA and oncoprotein overexpression are associated with distict morphological patterns of tonsillar squamous cell carcinoma. Am J Pathol 1998; 152: 145-56. Yeudall WA. Human papillomaviurs and oral neoplasia. Eur J Cancer B Oral Oncol 1992; 28: 61-6. Young SK, Min KW. In situ DNA hybridization analysis of oral papillomas, leukoplakias and carcinomas for human papillomavirus. Oral Surg Oral Med Oral Pathol 1991; 71: 726-9. Zaitsu K, Ohkura Y. New fluorogenic substates for horseradish peroxidase: rapid and sensitive assays for hydrogen peroxide and the perosidase. Anal Biochem 1980; 109: 109-13. Zitz JC, McLachlin CM, Tate JE, Mutter GL, Crum CP. Restriction fragment length polymorphism analysis of isotope-labeled polymerase chain reaction-amplified human papillomavirus DNA combines sensitivity with built-in contaminant detection. Mod Pathol 1994; 7: 407-11. Zoltan S, Imre S, Ildiko B, Karoly P, Eva R, Laszlo T,Gabriella S, Zsombor M, Pal N, Miklos K. Causal association between human papillomavirus infection and head and neck and esophageal squamous cell carcinoma. Hungarian Oncol 2002; 46: 35-41. Zur Hausen H. Papillomavirus infection - a major cause of human cancers. Biochim Biophs Acta 1996; 1288: 55-78. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/32850 | - |
dc.description.abstract | 背景及目的:過去許多研究證實高危險 (high-risk) 人類乳頭瘤病毒 (Human papillomavirus, HPVs) 和子宮頸及口腔鱗狀細胞癌,有相當有意義之相關。但是於口腔疣狀癌的發生上,人類乳頭瘤病毒所扮演的角色,還並不清楚。於本研究中我們將探討全部基因型人類乳頭瘤病毒,特別是高危險基因型人類乳頭瘤病毒和口腔疣狀癌之發生,是否有相關。
方法: 為了探討人類乳頭瘤病毒在口腔疣狀癌致癌機轉上所扮演的角色,本實驗於75個口腔疣狀癌標本及30個正常口腔黏膜標本中,純化出去氧核糖核酸 (DNA),利用兩組位在人類乳頭瘤病毒中,一致性較高的L1部份的引子(MY09/GP6+ 和 GP5+/GP6+),進行兩次聚合酶鏈反應 (polymerase chain reaction, PCR),來增加人類乳頭瘤病毒的DNA量,以供偵測。同時配合人類乳頭瘤病毒生物晶片 (gene chip), 及DNA定序技術,來作人類乳頭瘤病毒定型 (typing),以此方法可在一次反應中,偵測出39種不同人類乳頭瘤病毒的基因型。 結果: 我們發現,就全部基因型人類乳頭瘤病毒的陽性率而言,口腔疣狀癌標本 (15%, 11/75) 和正常口腔黏膜標本 (20%, 6/30),及口腔習慣相關口腔疣狀癌標本 (14%, 10/71) 和口腔習慣無相關口腔疣狀癌標本 (25%, 1/4),皆無顯著差異 (P>0.05);就高危險、低危險或不明危險基因型人類乳頭瘤病毒的陽性率而言,口腔疣狀癌標本(分別為4%, 11% 或 15%) 和正常口腔黏膜標本 (分別為17%, 3% 或0%, P>0.05),及口腔習慣相關口腔疣狀癌標本 (分別為3%, 11% 或 3%) 和口腔習慣無相關口腔疣狀癌標本 (分別為25%, 0% 或 0%),也皆無顯著差異 (P>0.05);然而,就人類乳頭瘤病毒基因型 16和多種人類乳頭瘤病毒基因型同時出現於同一標本的陽性率而言,正常口腔黏膜標本 (分別為17% 和 13%) 明顯大於口腔疣狀癌標本(分別為0% 和 1%, P<0.05)。於11個人類乳頭瘤病毒陽性的口腔疣狀癌標本中,低危險基因型 (11, 72和74) 之出現頻率 (73%),高於高危險基因型 (18和31) 之出現頻率 (27%),及不明危險基因型 (53和62) 之出現頻率 (18%),但其差別無統計意義。 結論: 因和正常口腔黏膜標本相較,口腔疣狀癌,特別是口腔習慣相關口腔疣狀癌,之全部基因型及高危險基因型人類乳頭瘤病毒的陽性率仍然偏低,我們認為口腔疣狀癌,特別是口腔習慣相關口腔疣狀癌,和全部基因型及高危險基因型人類乳頭瘤病毒,無明顯相關。 | zh_TW |
dc.description.abstract | Background and purpose: Previous studies have shown a significant association of high-risk human papillomavirus (HPV) types with cervical and oral squamous cell carcinomas. However, the etiologic role of HPV in the development of oral verrucous carcinoma (OVC) is still unclear. In this study, we tried to elucidate whether there was a close relationship between all or high-risk HPV types and OVCs.
Methods: DNA samples were purified from 75 OVC specimens and 30 normal oral mucosa (NOM) specimens. A nested polymerase chain reaction (PCR) was used to amplify the consensus L1 region of the HPV genome in DNA samples using two sets of HPV primers (MY09/GP6+ and GP5+/GP6+). This procedure combined with a gene chip HPV typing and DNA sequencing was able to detect 39 HPV subtypes in our samples. Results: We found no significant difference in the overall HPV-positive rate between OVC samples (15%, 11/75) and NOM samples (20%, 6/30, P>0.05) as well as between OH-associated OVC samples (14%, 10/71) and non-OH-associated OVC samples (25%, 1/4, P>0.05). In addition, there was also no significant difference in the positive rate of high-risk, low-risk or unclear-risk HPV types between OVC samples (4%, 11% or 3%, respectively) and NOM samples (17%, 3% or 0%, respectively, P>0.05) as well as between OH-associated OVC samples (3%, 11% or 3%, respectively) and non-OH-associated OVC samples (25%, 0% or 0%, respectively, P>0.05). However, HPV type 16 and multiple HPV types were detected more frequently in NOM samples (17% and 13%, respectively) than in OVC samples (0% and 1%, respectively, P<0.05). In 11 HPV-positive OVC samples, low-risk types (11, 72 and 74) were found more frequently (73%, 8/11) than high-risk types (18 and 31; 27%, 3/11) or unclear-risk types (53 and 62; 18%, 2/11), but the difference was not significant (P>0.05). Conclusion: The relatively low overall and high-risk HPV-positive rates in our OVC samples, especially in OH-associated OVC samples, compared to those in NOM samples suggest that there is no significant association of all and high-risk HPV types with OVCs, especially OH-associated OVC. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T04:17:09Z (GMT). No. of bitstreams: 1 ntu-95-P91422003-1.pdf: 375336 bytes, checksum: cb6ecffddd84b01aea03944a760623c0 (MD5) Previous issue date: 2006 | en |
dc.description.tableofcontents | 中文摘要..............................................7
Abstract..............................................9 Introduction..........................................11 Background............................................13 Purposes of this study................................14 Literature Review Part 1: Introduction of oral verrucous carcinoma......15 (I) Epidemiology (II) General introduction (III) Clinical presentation (IV) Histological features (V) Differential diagnosis and therapy Part 2: Introduction of human papillomaviruses.........19 (I) General view of HPV 1. HPV genome organization A. Viral structure B. Viral genome C. Viral polypeptides and proteins 2. Natural history of HPV infection 3. Transmission modes of HPV 4. Events leading to malignant progression 5. Extent of the human papillomaviruses in cervical cancer (II) Pathogenesis of human papillomaviruses in cervical cancer (III) The relationship of oral verrucous carcinoma to HPV Part 3: Method for detection and typing of HPV infection..........................................31 (I) Review of in situ hybridization (II) Compare the methods for detection: in situ hybridization, PCR, nested-PCR assay sensitivity (III) Comparison of methods for typing: in situ hybridization, RFLP, nested-PCR and microarray Material and Methods Part 1: patients and specimens…………………………35 Part 2: DNA extraction…………………………………36 Part 3: HPV detection by the nested-PCR………………37 Part 4: HPV genotyping by DNA sequencing……………38 Part 5: HPV genotyping by gene chip……………………38 Part 6: Statistical analysis………………………………39 Results…………………………………………………41 Discussion………………………………………………43 Conclusions……………………………………………47 References……………………………………………49 Tables…………………………………………………65 Figures…………………………………………………70 | |
dc.language.iso | en | |
dc.title | 人類乳頭瘤病毒與口腔疣狀癌的關係 | zh_TW |
dc.title | The relationship between human papillomavirus and oral verrucous carcinomas | en |
dc.type | Thesis | |
dc.date.schoolyear | 94-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 關學婉,張龍昌 | |
dc.subject.keyword | 人類乳頭瘤病毒,口腔疣狀癌,人類乳頭瘤病毒生物晶片, | zh_TW |
dc.subject.keyword | HPV,verrucous carcinoma,gene chip, | en |
dc.relation.page | 69 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2006-07-25 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
顯示於系所單位: | 臨床牙醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-95-1.pdf 目前未授權公開取用 | 366.54 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。